Bhavya G. Email & Phone Number

Washington DC-Baltimore Area

- Leading the Diagnostics’ program’s market access and commercialization portfolio, including a strategic initiative to partner with impact investors, development finance institutions, and diagnostic manufacturers in emerging markets to deploy blended finance models that boosts local supply security of diagnostics.- Supervising three direct reports who.

Washington D.C.

• Drove consensus among global SRH donors (BMGF, CIFF, FCDO, UNFPA, USAID) to support market sustainability of DMPA-SC, a self-injectable contraceptive, by facilitating senior-level discussions and driving decision making.
• Developed three-year strategy and vision for Living Labs, a new initiative embedding human-centered design (HCD) and insight generation expertise within PATH country offices. Oversaw program design and strategic.
• Scaled up Living Labs’ operations as a startup country based-HCD initiative by growing relationships with donors, global health agencies, implementing partners, and other stakeholders. Expanded Living Labs from three.
• Assisted with mobilizing a $3.5M investment from BMGF to characterize the market for eight maternal, neonatal, and child health (MNCH) medical devices in four sub-Saharan African countries.

Washington D.C. (2/15-10/17) ; Johannesburg, South Africa (11/17 - 8/19)

• Managed and executed market dynamics-related activities for a $10M project funded by BMGF and CIFF, focused on scaling up DMPA-SC. - Led costing work for national DMPA-SC introduction planning in 5 countries (DRC.
• Oversaw the implementation of a 3yr BMGF market dynamics project to improve access to cervical precancer treatment in LMICs. - Assessed and recommended market-based solutions to increase access to and use of cervical.
• Spearheaded market dynamics activities on additional projects, including: - Led PATH’s innovation ecosystem efforts in South Africa, partnering directly with the South African Medical Research Council (SAMRC) to.

Washington D.C. Metro Area

• Conducted situational assessment for radiotherapy treatment in Kenya, Uganda, and Ethiopia, resulting in high-level discussions with private radiotherapy manufacturers, the International Atomic Energy Agency (IAEA) and.
• Led ACS’ expansion of work into Ethiopia. Directly oversaw the hiring of a local consultant, established a Memorandum of Understanding with the Ethiopian Federal Ministry of Health (MOH), and guided the development of.
• Planned and oversaw the launch of Pain-Free Hospital Initiative in 10 hospitals across Kenya and Ethiopia.

Maseru, Lesotho

• Directed CHAI-Lesotho’s expansion of work into tuberculosis (TB) diagnostics and medicines by developing situational analyses for existing CHAI programs, resulting in securing $150,000 annually from BMGF and the UK.
• Conducted forecasting and quantification for over 10 pharmaceuticals and health products for a Global Fund (GF) HIV-related grant, equaling over $35M USD in health commodities over the 3 year grant period.
• Led contract negotiations between the MOH and private sector diagnostic manufacturers to maximize financial resources, resulting in reduced pricing and improved supply of laboratory commodities to avert gaps in HIV and.
• Provided technical assistance for quantification and forecasting, procurement and supply chain management (SCM) of medicines, laboratory commodities, and vaccines in coordination with the MOH and other partners.
• Created scenario optimization model for Lesotho’s GeneXpert roll-out which aided in securing GF funding to procure consumables for the national TB program.
• Worked with the MOH in drafting national program strategies and policies, including the National Point of Care Policy, the Tuberculosis National Strategic Plan, and the National SCM Strategic Plan to improve consistent.

Addis Ababa, Ethiopia

• Assisted the Ethiopian Health and Nutrition Research Institute (EHNRI) to operationalize the National Master Plan for laboratory service capacity building, including the development of national guidelines, strategies.
• Managed the country-wide SMS printer project by collaborating and communicating with six regional laboratories and 25 health facilities that provided Early Infant Diagnostic (EID) services. Developed the strategic.

Masters in Sciences of Public Health (MSPH) with a concentration in International Health, Health Systems

• Associate within the Life Sciences Advisory Services practice, focused on clinical research compliance for academic medical centers, universities, and hospitals.
• Conducted an assessment of clinical research billing operations and compliance for two major academic medical centers. Provided recommendations for major changes and prepared a report for leadership that influenced.
• Performed a high-level assessment of clinical research operations, clinical research billing compliance, and the human research protection program for two major community hospitals. Provided implementation.

• Analyst within the Clinical Research Solutions and Healthcare Compliance (CRSHC) practice, focused on clinical research compliance for academic medical centers, universities, and hospitals.
• Supported a major community hospital to enhance the institution’s clinical trial operations. Performed Medicare Coverage Analyses (MCAs) for over 30 medical device or drug protocols and utilized MCAs to conduct claims.
• Reviewed and processed over 150 Institutional Review Board (IRB) applications at a large state university, communicated regulatory stipulations to the research community, and interfaced directly with the IRB Chair.
• Analyzed spend, vendor, manufacturing, packaging, and shipping data for a $2B global pharmaceutical company. Extracted findings to communicate trends, identified bottlenecks, and highlighted areas for supply chain.

Bba, Finance

Msph, Public Health - International Health